다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Beam Therapeutics Inc (BEAM)
Beam Therapeutics Inc (BEAM) 뉴스

BEAM

Beam Therapeutics (BEAM)

Beam Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BEAM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/11	06:23	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BEAM	Beam Therapeutics Inc
2025/03/11	06:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BEAM	Beam Therapeutics Inc
2025/03/10	19:13	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NASDAQ:BEAM	Beam Therapeutics Inc
2025/03/10	19:10	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:BEAM	Beam Therapeutics Inc
2025/03/10	19:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BEAM	Beam Therapeutics Inc
2025/03/10	19:01	GlobeNewswire Inc.	Beam Therapeutics Announces Pricing of Underwritten Offering	NASDAQ:BEAM	Beam Therapeutics Inc
2025/03/10	19:00	GlobeNewswire Inc.	Beam Therapeutics Announces Positive Initial Data for BEAM-302 in the Phase 1/2 Trial in Alpha-1 Antitrypsin Deficiency (AATD), Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/25	21:51	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/25	21:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/25	21:00	GlobeNewswire Inc.	Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/24	21:00	GlobeNewswire Inc.	Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/21	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/20	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/15	06:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/04	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/04	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/04	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/04	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/02/04	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/01/31	06:12	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/01/30	21:00	GlobeNewswire Inc.	Beam Therapeutics to Participate in Guggenheim SMID Cap Biotech Conference	NASDAQ:BEAM	Beam Therapeutics Inc
2025/01/23	21:00	GlobeNewswire Inc.	Beam Therapeutics to Encore Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at 2025 Tandem Meetings of ASTCT and CIBMTR	NASDAQ:BEAM	Beam Therapeutics Inc
2025/01/13	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BEAM	Beam Therapeutics Inc
2025/01/13	21:00	GlobeNewswire Inc.	Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts	NASDAQ:BEAM	Beam Therapeutics Inc
2025/01/07	07:49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/01/07	07:48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2025/01/03	10:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2024/12/31	09:29	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2024/12/31	09:26	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:BEAM	Beam Therapeutics Inc
2024/12/20	06:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BEAM	Beam Therapeutics Inc

검색 관련기사 보기:NASDAQ:BEAM

1 2 3 4 5 6 7 8 9 10 다음 >>

Haverty Furniture Compan...

Euronext G Societe Gener...

Blockchain of Hash Power

Gs Green Bd Gbp

Tradeweb Markets

Molson Coors Beverage

Antofagasta 34s

Cropper (james)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관